8-K//Current report
Helix Acquisition Corp. II 8-K
Accession 0001213900-25-072312
$BBOTCIK 0001869105operating
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 7:34 AM ET
Size
214.2 KB
Accession
0001213900-25-072312
Documents
- 8-Kea0251994-8k_helix2.htmPrimary
CURRENT REPORT
- EX-99.1ea025199401ex99-1_helix2.htm
PRESS RELEASE, DATED AUGUST 6, 2025
- EX-101.SCHhlxb-20250806.xsd
XBRL SCHEMA FILE
- EX-101.LABhlxb-20250806_lab.xml
XBRL LABEL FILE
- EX-101.PREhlxb-20250806_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-072312-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0251994-8k_helix2_htm.xml
IDEA: XBRL DOCUMENT
Issuer
BridgeBio Oncology Therapeutics, Inc.
CIK 0001869105
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001869105
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 7:34 AM ET
- Size
- 214.2 KB